Screen Shot 2018-11-21 at 11.04.06 am.png

next BIOTECH - Zero Safety Issues for IMU’s Immunotherapy Cancer Treatment: Phase II Trial Imminent

November 13, 2018


Screen Shot 2018-09-06 at 12.50.42 pm.png

The Australian Financial Review - Why it’ll pay to be more open to biotech investment opportunities

July 31, 2018


Screen Shot 2018-12-11 at 8.56.23 am.png

The Sydney Morning Herald - Cancer-fighter Imugene looking to spark interest of big pharma

July 2, 2018


Screen Shot 2018-09-06 at 12.54.41 pm.png

The Australian Financial Review - Imugene to raise $20m, fund trials at Ohio State University, Mayo Clinic

June 6, 2018


Screen Shot 2018-09-17 at 2.05.01 pm.png

The Australian - Biotech entrepreneur Hopper brings companies to life

May 14, 2018


Screen Shot 2018-09-06 at 11.42.39 am.png

The Australian Financial Review -  New thinking answers call of progress

April 7, 2017


Screen Shot 2018-09-06 at 11.49.34 am.png

The Australian Business Review - Imugene CEO Leslie Chong: meet the unicorn leading the cancer fight

March 5, 2017


Screen Shot 2018-09-06 at 11.53.54 am.png

The Sydney Morning Herald - Breakthrough for local biotech as an influential backer emerges

March 3, 2017


Screen Shot 2018-09-06 at 12.18.52 pm.png

Life Scientist - Imugene candidate increases cancer-fighting antibodies

April 20, 2017


Screen Shot 2018-09-06 at 12.20.42 pm.png

Bionity.com - HER-Vaxx Re-formation shows dramatic ten-fold increase in Antibodies and early onset of response

April 22, 2017


Screen Shot 2018-09-06 at 12.28.37 pm.png

Global Health and Travel - Cancer Vaccines, The New Wave of Immune System-Based Oncology

April 2015


Screen Shot 2018-09-06 at 12.39.02 pm.png

Proactive Investors -  Imugene meets heavy demand in capital raising for HER-Vaxx

December 9, 2014


Screen Shot 2018-09-06 at 12.41.57 pm.png

Proactive Investors - HER-Vaxx peptides demonstrate high level of activity

December 1, 2014 


Screen Shot 2018-09-06 at 12.44.54 pm.png

Life Scientist - Imugene Engages Mymetics to Manufacture HER-Vaxx Cancer Immunotherapy

July 16, 2014


Screen Shot 2018-09-06 at 1.00.57 pm.png

Life Scientist - Imugene picks peptide manufacturer for HER-Vaxx

May 28, 2014


Screen Shot 2018-09-06 at 1.03.53 pm.png

Proactive Investors - Imugene to be granted patent for cancer vaccine in Israel

March 24, 2014


Screen Shot 2018-09-06 at 1.09.01 pm.png

Life Scientist - Imugene kicks off IND process for HER-Vaxx

March 18, 2014